Activated Charcoal

證據等級: L5

預測適應症: 0 個

Activated Charcoal: Emergency Toxin Adsorption Agent — No TxGNN Predictions Available

One-Sentence Summary

Activated charcoal is a broad-spectrum gastrointestinal adsorbent primarily used in emergency medicine for acute poisoning and drug overdose management. The current TxGNN analysis returned no predicted new indications for this drug. As a result, a formal drug repurposing evaluation cannot be completed without re-running the prediction pipeline with complete input data.

Quick Overview

Item	Content
Original Indication	Acute poisoning / Toxin adsorption (emergency use)
Predicted New Indication	None — no TxGNN predictions generated
TxGNN Prediction Score	N/A
Evidence Level	L5 (no predictions or supporting studies retrieved)
Malaysia Market Status	✓ Marketed
Number of Registrations	3
Recommended Decision	Hold

Why No Predictions Are Available

The predicted_indications array in this Evidence Pack is empty. This typically occurs for one or more of the following reasons:

Mapping failure: Activated charcoal may not have been matched to a node in the TxGNN knowledge graph. Because it is a non-specific physical adsorbent rather than a targeted small molecule, it may lack the pharmacological fingerprint (receptor binding, enzymatic targets) required for graph-based similarity scoring.
Score threshold filtering: Any candidate predictions may have been removed by the post-processing score cutoff before reaching this report.
Pipeline incompleteness: The Evidence Pack was flagged with two blocking/high-severity data gaps (DG001: TFDA warnings, DG002: MOA), which may have halted downstream prediction steps.

Until the prediction pipeline is re-run with resolved data gaps, there is no repurposing hypothesis to evaluate.

Malaysia Market Information

Three product registrations are confirmed in the NPRA database, but the detailed licence records (product names, dosage forms, approved indications) were not retrieved in this data pull.

Item	Status
Number of Registered Products	3
Market Status	✓ Marketed
Detailed Licence Records	Not retrieved — requires a targeted NPRA record lookup

To populate the full licence table, re-query the NPRA portal with the individual product registration numbers associated with DB09278.

Safety Considerations

Please refer to the package insert for safety information.

Note: Both the TFDA package insert warnings/contraindications (DG001, severity: Blocking) and drug interaction data were absent from this Evidence Pack. These must be resolved before any safety assessment can proceed.

Conclusion and Next Steps

Decision: Hold

Rationale: There are no TxGNN-predicted indications to evaluate, and two critical data gaps (MOA and regulatory safety text) remain unresolved, making it impossible to assess either mechanistic plausibility or safety at this stage.

To proceed, the following is needed:

Resolve DG001 (Blocking): Download and parse the TFDA package insert PDF to extract approved indications, warnings, and contraindications.
Resolve DG002 (High): Query the DrugBank API for DB09278 to retrieve mechanism of action, drug categories, and toxicity data.
Re-run TxGNN prediction pipeline: After confirming that activated charcoal maps correctly to a knowledge graph node, re-execute run_kg_prediction.py to generate scored repurposing candidates.
Verify NPRA licence details: Retrieve the three product registration records in full (product name, dosage form, approved indication text) from the NPRA database.
Confirm KG node eligibility: Determine whether activated charcoal is represented as a tractable node in the TxGNN knowledge graph (data/node.csv); if absent, assess whether a surrogate compound or a mechanism-level placeholder can be used.
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.